杂志简称：hematol oncol
中文译名：《血液系统肿瘤学》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：3.90%
投稿方向：医学、hematology 血液学、oncology 肿瘤学
SCI/E期刊基本信息
出版周期：年5期 地区：英国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN0278-0232；EISSN1099-1069
杂志语言：英语
出版国家：英国
杂志官网 联系方式
出版地址：JOHN WILEY & SONS LTD,THE ATRIUM,SOUTHERN GATE,CHICHESTER,ENGLAND,W SUSSEX,PO19 8SQ
杂志邮箱：
投稿网址：http://mc.manuscriptcentral.com/hon
杂志官方网址：https://onlinelibrary.wiley.com/journal/10991069
出版商网址：http://www.wiley.com/WileyCDA/
杂志投稿要求
投稿须知【杂志社官方网站信息】
Author Guidelines
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/hon.
Click here for more details on how to use ScholarOne.
Data protection
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
Preprint policy
This journal will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the submitted version of a manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
For help with submissions, please contact: HONedoffice@wiley.com.
2. AIMS AND SCOPE
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:
Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
Diagnostic investigations, including imaging and laboratory assays
Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.
We work together with Wiley’s open access journal, Clinical Case Reports, to enable rapid publication of good quality case reports that we are unable to accept for publication in our journal. Authors of case reports rejected by our journal will be offered the option of having their case report, along with any related peer reviews, automatically transferred for consideration by the Clinical Case Reports editorial team. Authors will not need to reformat or rewrite their manuscript at this stage, and publication decisions will be made a short time after the transfer takes place. Clinical Case Reports will consider case reports from every clinical discipline and may include clinical images or clinical videos. Clinical Case Reports is an open access journal, and article publication fees apply. For more information please go to Clinical Case Reports.